[1] Aigner T, McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage [J]. Cell Mol Life Sci, 2002, 59(1):5-18. [2] 杨珺,郭雄,张增铁,等大骨节病患者关节软骨细胞凋亡及相关调控因子Bcl-2表达分布的特点[J].中国地方病学杂志,2002,21(5):341-3.Yang J, Guo X, Zhang ZT, et al. The distributed characteristics of chondrocyte apoptosis and the expression of Bcl-2 in articular cartilage with Kashin-Beck disease [J]. Chin J Endemiol, 2002, 21(5):341-3. [3] Robert K, Schen K, Peter SE, et al. Articular cartilage biochemistry[M]. New York:Raven Press, 1986.3-22. [4] Roach HI, Aigner T, Erenpeisa J. Ostegenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis[J]. J Cell Biol, 1995, 131(3):483-91. [5] Yang TS, Hou LZ, Li FS. Biochemical characteristics of Kashin-Beck disease [A]. In:Kashin-Beck disease and non-communicable diseases [M]. Beijing:Chinese Academy of Preventive Medicine,1990. 116-28. [6] 郭雄,Thomas A,Pirkko L,等.大骨节病关节软骨胶原表型表达和软骨细胞异常分化的研究[J].中华病理学杂志,1998,27(1):19-22.Guo X, Thomas A, Pirkko L, et al. A study on abnormal chondrocyte differentiation and abnormal expression of collagen types in AC from patients with Kashin-Beck disease[J]. Chin J Pathol, 1998,27(1):19-22. [7] Kim HA, Lee YJ, Seong SC, et al. Apoptotic chondrocyte death in human osteoarthritis [J]. J Rheumatol, 2000, 10(10):455-62. [8] Cheng EH, KirschDG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspase [J]. Science, 1997, 278(5345):1966-8. [9] Hashimoto S, Takahashi H, Aiel D, et al. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis[J]. Arthritis Rheum, 1998, 41(9):1226-34. [10] 张宝弟,郭雄,白广禄,等.大骨节病患者血清NO,NOS,sFas/APO-1检测分析[J].中国地方病学杂志,2004,31(4):172-5.Zhang BD, Guo X, Bai GL, et al. The changes of nitric oxide, NO synthase and sFas/Apo-1 in serum among the patients with Kashin-Beck disease[J]. Chin J Endemiol, 2004, 31(4):172-5. |